The Diagnostic Value of Macrophage Migration Inhibitory Factor (MIF) in Gastric Cancer
- First Online:
- Cite this article as:
- Camlica, H., Duranyildiz, D., Oguz, H. et al. Pathol. Oncol. Res. (2008) 14: 79. doi:10.1007/s12253-008-9002-7
- 92 Downloads
The present study was conducted to investigate the sensitivity, specificity, predictive values and accuracy of serum MIF, CEA, CA 19-9 levels and their various combinations in patients with gastric cancer. Study group consists of pathologically verified, gastric cancer (n = 63) and apparently healthy controls (n = 50). Serum MIF concentrations were determined by enzyme-linked immunosorbent assay (ELISA). Serum values of patients were significantly higher than the controls (p = 0.011). Diagnostic sensitivity and specificity, predictive values and accuracies were calculated for each marker and their various combinations. The best results were achieved with the marker combination of MIF–CEA–CA 19-9 and MIF–CEA combination. In our opinion, the combination of the markers MIF–CEA is a valuable diagnostic tool for gastric cancer.